Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEO
2951
CALL
DELISTED
CNOOC Limited
CEO
| $1.28M | ﹤0.01% |
7,500
-500
| -6% | -$83.1K |
|
2952
M/I Homes
MHO
$3.72B
| $1.28M | ﹤0.01% |
48,428
+32,067
| +196% | +$956K |
|
2953
Regenxbio
RGNX
$715M
| $1.28M | ﹤0.01% |
17,878
-2,637
| -13% | -$126K |
|
2954
Lumentum
LITE
$66.8B
| $1.28M | ﹤0.01% |
22,123
-87,947
| -80% | -$5.24M |
|
|
GES
2955
DELISTED
Guess Inc
GES
| $1.28M | ﹤0.01% |
59,862
-100,376
| -63% | -$2.31M |
|
2956
CNO Financial Group
CNO
$5.15B
| $1.28M | ﹤0.01% |
67,090
-149,350
| -69% | -$3.09M |
|
2957
Direxion Daily Financial Bull 3x ETF
FAS
$2.46B
| $1.28M | ﹤0.01% |
20,295
-9,002
| -31% | -$590K |
|
2958
Flowers Foods
FLO
$1.53B
| $1.28M | ﹤0.01% |
61,348
+32,593
| +113% | +$696K |
|
2959
CALL
Parker-Hannifin
PH
$134B
| $1.28M | ﹤0.01% |
8,200
-5,700
| -41% | -$972K |
|
2960
Invesco S&P 500 Low Volatility ETF
SPLV
$7.2B
| $1.28M | ﹤0.01% |
26,945
+10,014
| +59% | +$470K |
|
2961
CALL
Brinker International
EAT
$9.68B
| $1.28M | ﹤0.01% |
+26,800
| New | +$1.19M |
|
2962
Tandem Diabetes Care
TNDM
$1.28B
| $1.27M | ﹤0.01% |
57,774
+10,674
| +23% | +$131K |
|
|
DO
2963
CALL
DELISTED
Diamond Offshore Drilling
DO
| $1.27M | ﹤0.01% |
61,000
+10,900
| +22% | +$203K |
|
|
BPMC
2964
DELISTED
Blueprint Medicines
BPMC
| $1.27M | ﹤0.01% |
20,003
+7,946
| +66% | +$632K |
|
|
MODV
2965
DELISTED
ModivCare
MODV
| $1.27M | ﹤0.01% |
16,163
+3,113
| +24% | +$234K |
|
2966
CALL
Sinclair Inc
SBGI
$1.14B
| $1.27M | ﹤0.01% |
39,500
-28,500
| -42% | -$853K |
|
2967
CALL
Coherent
COHR
$66.1B
| $1.27M | ﹤0.01% |
29,200
-13,100
| -31% | -$578K |
|
|
DMC
2968
Del Monte Corp
DMC
$1.42B
| $1.26M | ﹤0.01% |
28,394
-35,979
| -56% | -$1.68M |
|
2969
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $1.26M | ﹤0.01% |
6,187
+5,060
| +449% | +$1.01M |
|
|
MRTX
2970
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.26M | ﹤0.01% |
25,651
-14,549
| -36% | -$550K |
|
2971
PUT
Alerian MLP ETF
AMLP
$12.9B
| $1.26M | ﹤0.01% |
25,020
+1,120
| +5% | +$56.8K |
|
2972
CALL
Lear
LEA
$8.11B
| $1.26M | ﹤0.01% |
6,800
-3,500
| -34% | -$685K |
|
|
WDR
2973
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $1.26M | ﹤0.01% |
70,329
-237,330
| -77% | -$4.62M |
|
|
DNKN
2974
CALL
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $1.26M | ﹤0.01% |
18,300
-5,000
| -21% | -$322K |
|
2975
Integer Holdings
ITGR
$4.25B
| $1.26M | ﹤0.01% |
19,546
+10,110
| +107% | +$627K |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,613 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.